Tocilizumab and Baricitinib for Recovery From Acute Exacerbation of Combined Pulmonary Fibrosis and Emphysema Secondary to COVID-19 Infection: A Case Report

Pneumonia secondary to coronavirus disease 2019 (COVID-19) is exacerbated by a disproportionate increase in the systemic inflammatory response and cytokine storm due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Herein, we report the successful treatment of severe COVID-...

Descripción completa

Detalles Bibliográficos
Autores principales: Kai, Yoshiro, Matsuda, Masayuki, Suzuki, Kentaro, Kasamatsu, Takehito, Kajita, Akihiro, Uno, Kenji, Muro, Shigeo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033509/
https://www.ncbi.nlm.nih.gov/pubmed/35481309
http://dx.doi.org/10.7759/cureus.23411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033509/
https://www.ncbi.nlm.nih.gov/pubmed/35481309
http://dx.doi.org/10.7759/cureus.23411

Ejemplares similares